Adjusted EBITDA margin reaches 37.9% as the Danish biosolutions company confirms 7–8% full-year organic growth guidance IN BRIEFKEY TAKEAWAYSFAQs Novonesis reported 7% organic sales growth and a 37.9% adjusted EBITDA margin for the first nine months of 2026, with third-quarter … Read the full press release →